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Abstract
Background: Women have a higher prevalence of Major Depressive Disorder (MDD) and report more severe depressive
symptoms than men. Several studies have suggested that gender differences in depression may occur because women
report higher levels of somatic symptoms than men. Those studies, however, have not controlled or matched for non-
somatic symptoms. The objective of this study was to examine if women report relatively more somatic symptoms than
men matched on cognitive/affective symptoms.
Methods: Male and female patients receiving treatment for MDD in outpatient psychiatric clinics in New Jersey and
Pennsylvania, USA were matched on Beck Depression Inventory-II (BDI-II) cognitive/affective symptom scores. Male and
female BDI-II somatic symptom scores were compared using independent samples 2-tailed t-tests.
Results: Of 472 male and 1,026 female patients, there were 470 male patients (mean age=40.1 years, SD=15.1) and 470
female patients (mean age=43.1 years, SD=17.2) successfully matched on BDI-II cognitive/affective symptom scores.
Somatic symptoms accounted for 35% of total BDI-II scores for male patients versus 38% for matched female patients.
Female patients had somatic symptom scores on average 1.3 points higher than males (p,.001), equivalent to 4% of the
total BDI-II scores of female patients. Only 5% of male patients and 7% of female patients scored 2 or higher on all BDI-II
somatic symptom items.
Conclusions: Gender differences in somatic scores were very small. Thus, differences in the experience and reporting of
somatic symptoms would not likely explain gender differences in depression rates and symptom severity.
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Introduction
Women are 2–3 times more likely to experience Major
Depressive Disorder (MDD) than men [1,2] and have higher scores
on self-report depression symptom measures [3,4]. The higher
prevalence of MDD among women compared to men begins in
early adolescence and continues through adulthood [5,6]. Similarly,
women are more likely to be diagnosed with other psychiatric
disorders that involve physical symptoms, including somatoform
disorders, such as Somatization Disorder and Conversion Disorder
[7–9].Someofthesymptomsofthesedisordersoverlapsubstantially
with symptoms of MDD. Women may also more frequently report
other physical symptoms potentially related to emotional distress
(e.g., headache, back pain) than men [10–12].
Many studies have examined whether men and women report
somatic symptoms of depression differently or whether the number
of somatic symptoms reported by men and women might explain
gender differences in depression rates and severity [8,13–26]. Since
women have higher rates of depression than men, it would be
expected that women would have higher cognitive/affective and
somatic symptoms than men on average, but that the composition
of symptoms among men and women would be similar. Otherwise,
it would suggest that assessments of depression rates or severity may
reflect different symptoms for men and women. Among people
diagnosed with MDD, if there were more somatic symptoms among
women, this would raise the possibility that increased reporting of
somaticsymptomspotentiallyunrelatedtodepressionmayinfluence
the diagnosis of depression among women.
Two studies have used data from large US population surveys
to examine whether there were gender differences in the rates of
‘‘somatic depression’’ among people with MDD [21,22]. In those
studies, ‘‘somatic depression,’’ was defined as having appetite
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that women with MDD were twice as likely to endorse all three
somatic symptoms versus men with MDD and therefore, that
women with MDD were twice as likely to experience ‘‘somatic
depression’’ than men with MDD. Men conversely, were slightly
more likely than women to report a combination of cognitive/
affective and somatic symptoms or only cognitive/affective
symptoms. The conclusions of the studies suggested that
differences in rates of ‘‘somatic depression’’ could explain higher
rates of depression among women compared to men. However,
in one of the studies, which used data from the National
Comorbidity Survey, the absolute rate of ‘‘somatic depression’’
was only 8% for women with MDD and 4% for men with MDD
[21]. In the other study, which combined data from the National
Institute of Mental Health (NIMH) Collaborative Study on the
Psychobiology of Depression and the Epidemiologic Catchment
Area (ECA) Study, the absolute rates were 3% for women with
MDD and 1.5% for men with MDD [22]. Thus, among people
with MDD, somatic symptoms were more prominent among
women compared to men. Notably, however, although the
relative rate of ‘‘somatic depression’’ was larger for women, the
proportion of depressed men and women with ‘‘somatic
depression’’ was very small in both studies. Furthermore, the
absolute difference in rates of ‘‘somatic depression’’ was very
small. In addition, neither study controlled for the overall
number of symptoms endorsed. As such, it is possible that the
higher likelihood of endorsing all 3 somatic symptoms among
women compared to men reflected a higher number of
symptoms overall rather than increased somatic symptoms,
specifically.
Many other studies have examined whether there are gender
differences in the endorsement of individual depressive symptoms
[8,13–20,23–26]. The results of those studies, however, have been
inconsistent. Some studies have identified some somatic symptoms
more frequently reported by women, but not the same somatic
symptoms across studies [8,14–20,23–26]. On the other hand, a
number of studies have identified cognitive/affective symptoms
more frequently reported by women than men [8,13,15,23,24].
Thus, it is not clear whether and to what degree women report
higher levels of somatic symptoms than men with similar levels of
cognitive/affective symptoms. MDD is diagnosed per the DSM-IV
[9] based on the presence of at least 5 of 9 symptoms, including 1
of 2 core symptoms of depressed mood or anhedonia. For the
purpose of evaluating the relative somatic symptom burden of
women and men with MDD, however, continuous measures, such
as the Beck Depression Inventory-II (BDI-II) [27] may be
advantageous compared to simply counting symptoms. The
reason for this is that continuous measures assess a wider range
of symptom experiences and provide continuous scores that allow
parsing of variance into somatic and cognitive/affective compo-
nents. The objective of this study was to determine whether
women with MDD report higher levels of somatic symptoms on
the BDI-II than men with MDD matched on cognitive/affective
BDI-II symptoms.
Methods
Ethics Statement
This study was a secondary analysis of de-identified data from
studies that were originally approved by the institutional review
boards of the University of Medicine and Dentistry of New Jersey
and the University of Pennsylvania. All patients provided written
consent for their information to be stored in hospital databases and
used for research.
Participants and Procedure
The sample consisted of psychiatry outpatients ($18 years old)
with a primary DSM-IV diagnosis of MDD. Patients were
evaluated and diagnosed by experienced psychiatrists or psychol-
ogists at an outpatient psychiatric clinic associated with the
Department of Psychiatry, University of Medicine and Dentistry of
New Jersey or at the Beck Institute for Cognitive Therapy and
Research in Pennsylvania, USA. Patients completed the BDI-II at
intake, prior to beginning treatment, as part of a standard battery
of psychological tests. Patient participation was voluntary and
informed consent was obtained before the instruments were
administered.
Male and female patients who completed all BDI-II items were
matched on cognitive/affective symptom scores. To do this, the
number of male and female patients with each possible cognitive/
affective score was compared. In order to have the same number
of male and female patients at each cognitive/affective score level,
we included all patients at each cognitive/affective score level from
the group (male or female) with the smaller number of patients.
Then the same number of patients from the other group with that
cognitive/affective score was randomly selected. To do this, we
generated a random number for each patient using SPSS (normal
distribution, mean=0, standard deviation=1). We then selected
the appropriate number of patients from the larger group based on
random numbers, with the patients with the highest random
numbers selected. For example, if 10 male patients and 15 female
patients had cognitive/affective scores of 5, then all 10 male
patients were selected along with the 10 female patients with the
highest random numbers of the 15 female patients. Patients who
were not matched were not included in the primary analyses.
Measure
Symptoms of depression were assessed using the 21-item BDI-II
[27]. BDI-II items consist of four statements, scored 0–3, with
higher scores indicating increasing symptom severity. Respondents
are instructed to describe the way they have been feeling during
the past two weeks. There is extensive evidence of the validity and
reliability of the BDI-II in both psychiatric and non-psychiatric
populations [28,29]. Based on reviews of existing factor models
[30,31] and item content, scores on BDI-II items 1–14 (sadness,
pessimism, past failure, loss of pleasure, guilty feelings, punishment feelings,
self-dislike, self-criticalness, suicidal ideation, crying, agitation, loss of interest,
indecisiveness, worthlessness) were summed to calculate cognitive/
affective symptom scores. Items 15–21 (loss of energy, sleep problems,
irritability, appetite problems, concentration, fatigue, sexual disinterest) were
summed to calculate somatic symptom scores.
Analysis of the Data
Independent samples 2-tailed t-tests were used to test whether
matched male and female patients differed with regard to BDI-II
somatic symptom scores overall. Standardized mean differences
were calculated using the Hedges’s g statistic [32]. Male and
female patients’ somatic symptom item scores were similarly
compared. Hochberg’s Sequential Method was used to maintain a
family-wise Type I error rate of a,.05 for multiple comparisons
[33]. Two sensitivity analyses were also conducted. First, matched
male and female patients were compared using ANCOVA to
adjust for age. Second, to supplement the main analysis, we
analyzed data from all patients, rather than just matched patients,
by using linear regression to assess the difference on somatic
symptom scores between male and female patients, controlling for
BDI-II cognitive/affective symptom scores.
In addition, similar to Silverstein’s analyses of rates of male and
female patients with MDD who endorsed all somatic symptoms,
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symptom items were classified as exhibiting ‘‘somatic depression.’’
The x
2 statistic was used to compare the prevalence of ‘‘somatic
depression’’ between male and female patients.
Results
Sample Characteristics
Prior to matching, mean BDI-II scores were 27.5 (SD=11.5)
for 472 male patients and 29.8 (SD=12.0) for 1,026 female
patients. There were 470 exact matches using cognitive/affective
symptom scores, and matched females were on average 3 years
older than matched males (43.1 years, SD=17.2 versus 40.1 years,
SD=15.1, respectively, p=.005). The majority of male (89%) and
female (90%) patients were White.
BDI-II Somatic Symptom Scores
Post-match mean BDI-II scores were 27.5 (SD=11.5) for 470
male patients and 28.7 (SD=11.7) for 470 female patients. As
shown in Table 1, somatic symptom scores were 1.3 (95%
confidence interval [CI]=0.7 to 1.8) points higher among female
than male patients, equivalent to 4% of the mean total BDI-II
score of female patients (p,.001). Somatic symptoms accounted
for 35% of total BDI-II scores for male patients versus 38% for
female patients, a negligible raw difference of 3%. Hedges’s g for
the difference in somatic scores between male and female patients
was 0.30, which is a relatively small difference based on Cohen’s
operational definitions (small=0.2, medium=0.5, large=0.8)
[34]. The results for all the analyses were unchanged when
controlling for age (somatic symptom score difference=1.3, 95%
CI=0.8 to 1.8, p,.001). Results were also similar when somatic
symptom scores were regressed on sex and cognitive/affective
symptom scores (somatic symptom score difference=1.2, 95%
CI=0.8 to 1.5, p,.001) for all patients, rather than just matched
patients. As shown in Table 2, the higher somatic scores among
female patients were due to significantly higher scores on items 15
(loss of energy), 18 (appetite problems), 20 (tiredness or fatigue), and 21
(sexual disinterest).
BDI-II Somatic Depression
Overall, 5% (25 of 470) of male patients and 7% (34 of 470) of
female patients scored 2 or above on all seven BDI-II somatic
symptom items. There was no statistically significant difference
between male and female patients with regard to the prevalence of
‘‘somatic depression’’ based on scoring 2 or above on all seven
BDI-II somatic symptom items (loss of energy, sleep problems, irritability,
appetite problems, concentration, fatigue, sexual disinterest; p=.226).
Discussion
The main finding of this study was that BDI-II somatic
symptom scores were only minimally higher for female versus male
psychiatry outpatients with MDD matched on cognitive/affective
symptom scores. Women scored just over a point higher than men,
accounting for only 4% of their total BDI-II scores. Furthermore,
based on BDI-II somatic symptoms item scores, only 7% of
women versus 5% of men and were classified as having ‘‘somatic
depression.’’
These results, numerically, are consistent with results from two
prominent earlier studies that reported that ‘‘somatic depression’’
was twice as prevalent among women with MDD compared to
men with MDD [21,22]. In those two studies, rates of ‘‘somatic
depression’’ were 8% and 3% for women versus 4% and 1.5% for
men, respectively. In both of those studies, and in the present
study, however, more than 90% of men and women with MDD
were not classified as having ‘‘somatic depression.’’
The key difference between the present study and the two
earlier studies by Silverstein [21,22] is that the previous studies
focused on relative risk without interpreting the meaningfulness of
findings in terms of absolute risk. In the context of very low rates,
however, communication of relative risk is often highly misleading
[35–38]. For instance, increasing risk from 1 in 10,000 to 2 in
10,000 would technically be ‘‘double the relative risk,’’ but, in
most cases, would not be clinically meaningful. Silverstein
suggested that the increased relative risk of ‘‘somatic depression’’
for women was a possible explanation for gender differences in
depression rates and severity, but only a very small percentage of
MDD patients were classified as having ‘‘somatic depression,’’
which was also the case in the current study. Thus, the very minor
differences between rates of ‘‘somatic depression’’ for men and
women in all of these studies, along with the minimal gender
difference in BDI-II somatic symptom scores in the present study,
suggest that gender differences in depression are not adequately
explained in terms of somatic symptoms.
A number of other studies have examined whether there are
gender differences in the endorsement of depressive symptoms on
an item-by-item basis [8,13–20,23–26]. Some studies have found
that women are more likely to report certain somatic items,
including appetite disturbances, weight disturbances and fatigue
than men [8,14–20,23–26]. However, the specific somatic
symptoms identified as potentially different for men and women
are not the same across studies, and most somatic symptom items
analyzed show no differences. On the other hand, some studies
have reported that women are more likely than men to report
certain cognitive/affective items, such as tearfulness, feelings of
guilt, feelings of worthlessness, sexual disinterest and thoughts of
death, than men [8,13,15,23,24]. However, as with somatic
symptoms, consistent patterns do not emerge across studies and,
for most cognitive/affective symptoms examined, there are no
differences. Possible reasons that have been suggested to explain
these findings include the use of different methods to assess
symptoms of depression and different patients and settings [19]. In
addition, all of these studies conducted statistical tests on many
different items, without adjustment for multiple comparisons, and
based their conclusions of gender differences on differences in
small numbers of items among many tested. Given this, the
Table 1. Comparison of BDI-II Somatic Symptom Scores for Female Patients Versus Male Patients.
N Per Group
Mean Cognitive/Affective
Scores
1: Females and Males
Mean Somatic Scores
1:
Females (% Total Scores)
Mean Somatic Scores
1:
Males (% Total Scores)
Difference in Somatic Scores
1
(% Female Scores) P-Value
470 17.95 10.79 (37.5) 9.52 (34.7) 1.27 (4.4) ,.001
BDI-II=Beck Depression Inventory-II.
1Definitions of cognitive/affective and somatic scores in text.
doi:10.1371/journal.pone.0032490.t001
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differences overall, as we found in the present study. In the present
study, although we presented item-by-item data, our hypothesis
was tested based on a single comparison of differences in overall
somatic symptom scores.
There is no debating that women have higher rates of
depression and report more severe depressive symptoms than
men, and it is important to better understand how and why these
gender differences in depression occur in order to create more
efficacious treatments. The findings of this study, however, do not
support the existence of a somatic subtype of depression among
women that may explain gender differences in depression. Given
this finding, other explanations that have been advanced may be
more promising. For instance, it has been suggested that gender
differences in depression may be related to 1) prior anxiety, which
is more common among women than men [39], 2) the willingness
of women to admit their depression more than men [40], 3) the
tendency for women to ruminate about problems more than men
[41], 4) higher levels of stress and lower levels of fulfillment
associated with traditional male versus female sex roles [42], and 5)
hormonal changes during puberty [43].
One limitation of this study is that we studied a sample of adults
with MDD who sought treatment at one of two clinics in New
Jersey or Pennsylvania, USA, which could limit the generalizabil-
ity of results. On the other hand, the results of the study are
generally similar to Silverstein’s [21,22] previous findings using
larger, more representative samples of patients, and robustly
demonstrate that somatic symptom reporting is not likely an
explanation for gender differences. A second limitation of this
study is that, as in Silverstein’s studies [21,22], our definition of
‘‘somatic depression’’ was arbitrary. However, the amount of men
and women with ‘‘somatic depression’’ in this study was similar to
that in Silverstein’s studies [21,22] and facilitated comparisons.
Also, since different assessment methods were used, the definitions
of ‘‘somatic depression’’ were somewhat different. We used a
definition that was based on published factor analyses of the BDI-
II, which may differ somewhat from other conceptualizations. A
third limitation of this study is that we did not have information
regarding whether or not patients were diagnosed with additional
psychiatric diagnoses besides MDD and therefore, it is possible
that this sample may not be representative of patients only with
MDD. Lastly, other possible limitations of the study were that
MDD diagnoses were not based on a structured clinical interview
and that depressive symptoms were assessed using the BDI-II,
which is not a diagnostic tool. The BDI-II, however, does contain
the core symptoms that are covered in the DSM-IV. In addition,
using the BDI-II allowed for an assessment of continuous symptom
scores and overall contribution of somatic symptoms whereas a
structured clinical interview only permits counting the presence or
absence of symptoms.
In summary, it is well-known that women have a higher
prevalence of MDD and report more severe depressive symptoms
than men. The results of this study show that differences in the
experience and reporting of somatic symptoms explain only a
small portion of these gender differences. Future studies examining
this issue should focus on additional explanations.
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